The Medicines Patent Pool (MPP) was established in 2010 by Unitaid to increase access to affordable quality medicines for HIV and allow the development of new treatments, such as fixed-dose combinations and paediatric formulations. The model proved successful, and the mandate was expanded first to tuberculosis (TB) and hepatitis C in 2015, and then to other patented medicines on the World Health Organization (WHO) Essential Medicines List as well as COVID-19 more recently.
Over 10 years of operations, MPP has revolutionised the access to medicines landscape bringing nearly 12 billion doses of treatments to people across 131 countries. The power of partnership – with patent holders, generic manufacturers, patient groups, civil society and global stakeholders – lies at the heart of MPP’s work. This campaign celebrates 10 years of MPP’s vision and mission in leaving no one behind.
Explore further to hear about MPP’s work through the voices of our partners as we push for Access, Equity, Affordability, Availability, Speed, Transparency and so on, together.